Label: VASELINE- healing jelly jelly
-
NDC Code(s):
64942-1874-1,
64942-1874-2,
64942-1874-3,
64942-1874-4, view more64942-1874-5
- Packager: Conopco Inc. d/b/a Unilever
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 7, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- VASELINE HEALING JELLY - (petrolatum) jelly
- Active ingredient
- Purpose
- Uses
- Warnings
- KEEP OUT OF REACH OF CHILDREN
- Directions
- Inactive Ingredient
- Questions?
- Package
-
INGREDIENTS AND APPEARANCE
VASELINE
healing jelly jellyProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:64942-1874 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM 99.96 g in 100 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:64942-1874-1 49 g in 1 JAR; Type 0: Not a Combination Product 03/03/2021 2 NDC:64942-1874-2 71 g in 1 TUBE; Type 0: Not a Combination Product 03/03/2021 3 NDC:64942-1874-3 106 g in 1 JAR; Type 0: Not a Combination Product 03/03/2021 4 NDC:64942-1874-4 212 g in 1 JAR; Type 0: Not a Combination Product 03/03/2021 5 NDC:64942-1874-5 368 g in 1 JAR; Type 0: Not a Combination Product 03/03/2021 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part347 03/03/2021 Labeler - Conopco Inc. d/b/a Unilever (001375088)